Exact Mass: 395.9601778
Exact Mass Matches: 395.9601778
Found 43 metabolites which its exact mass value is equals to given mass value 395.9601778,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Sulconazole
C18H15Cl3N2S (396.00214800000003)
D - Dermatologicals > D01 - Antifungals for dermatological use > D01A - Antifungals for topical use > D01AC - Imidazole and triazole derivatives D000890 - Anti-Infective Agents > D000935 - Antifungal Agents C254 - Anti-Infective Agent > C514 - Antifungal Agent
Ethiprole
5,5'-Dithiobis(2-nitrobenzoic acid)
D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D013439 - Sulfhydryl Reagents
2,10-Dibromo-3-chloro-alpha-chamigrene
C15H23Br2Cl (395.98549080000004)
DTNB
D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D013439 - Sulfhydryl Reagents
2-Amino-3-methyl-5-[(5,6-dibromo-1H-indole-3-yl)methylene]-1-imidazoline-4-one
O1-(2-iodo-phenyl)-beta-D-glucopyranuronic acid|O1-(2-Jod-phenyl)-beta-D-glucopyranuronsaeure
3,8-dibromo-7-O-methylchlamydosporol|bromomethylchlamydosporol B
C12H14Br2O5 (395.92079140000004)
4-Iodophenol glucuronide|O1-(4-iodo-phenyl)-beta-D-glucopyranuronic acid|O1-(4-Jod-phenyl)-beta-D-glucopyranuronsaeure
3-amino-N-[3-oxo-2-(2,4,6-trichlorophenyl)-1H-pyrazol-5-yl]benzamide
C16H11Cl3N4O2 (395.99475559999996)
3-Amino-N-(5-oxo-1-(2,4,6-trichlorophenyl)-4,5-dihydro-1H-pyrazol-3-yl)benzamide
C16H11Cl3N4O2 (395.99475559999996)
D-Fructose, 1-(dihydrogen phosphate), barium salt (1:1)
C6H11BaO9P (395.91930460000003)
6-Iodo-1-(4-methoxybenzyl)-1H-pyrido[2,3-b][1,4]oxazin-2(3H)-one
7-Iodo-1-(4-methoxybenzyl)-1H-pyrido[2,3-b][1,4]oxazin-2(3H)-one
4-iodo-N-(2-morpholin-4-ylethyl)benzenesulfonamide
[6-O-Phosphono-κ2O,Ohexopyranosato(2-)]barium
C6H11BaO9P (395.91930460000003)
d-fructose-6-phosphate barium salt
C6H11BaO9P (395.91930460000003)
3-[(E)-3-anilino-3-oxoprop-1-enyl]-4,6-dichloro-1H-indole-2-carboxylic acid
C18H11Cl2N2NaO3 (396.00443960000007)
2-Bromo-N-[2-(2-chlorobenzoyl)-4-nitrophenyl]acetamide
C15H10BrClN2O4 (395.95124300000003)
2,3,3,4,4,5,5,6,6,7,7,8,8,8-Tetradecafluorooctanoic acid
2-Amino-4-(2-chlorophenyl)-6-[(4-chlorophenyl)thio]pyridine-3,5-dicarbonitrile
C19H10Cl2N4S (396.00032000000004)
1-[(7-Chloro-4-quinolinyl)amino]-3-(2,4-dichlorophenyl)thiourea
2-[(5-chloro-2-thiophenyl)sulfonylamino]-N-(2-furanylmethyl)benzamide
C16H13ClN2O4S2 (396.00052480000005)
2-Bromo-1-(4-methoxyphenyl)-3-[(4-methylphenyl)sulfonyl]-1-propanone
C17H17BrO4S (396.00308620000004)
1-(5-Bromo-2-thiophenyl)-2-[(5-methoxy-1-methyl-2-benzimidazolyl)thio]ethanone
[[Hydroxy(oxido)amino]oxy-nitrooxybismuthanyl] nitrate
sulconazole
C18H15Cl3N2S (396.00214800000003)
D - Dermatologicals > D01 - Antifungals for dermatological use > D01A - Antifungals for topical use > D01AC - Imidazole and triazole derivatives D000890 - Anti-Infective Agents > D000935 - Antifungal Agents C254 - Anti-Infective Agent > C514 - Antifungal Agent
Gavestinel (sodium salt)
C18H11Cl2N2NaO3 (396.00443960000007)
Gavestinel (GV 150526A) is a potent, selective, orally active and non-competitive antagonist of NMDA receptor. Gavestinel binds to the glycine site of the NMDA receptor, with a pKi of 8.5. Gavestinel can be used for the research of acute ischemic stroke[1].